These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 21421102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T, Pratt WB, Callery MP, Vollmer CM.
    J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
    [Abstract] [Full Text] [Related]

  • 3. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
    Barnett SP, Hodul PJ, Creech S, Pickleman J, Arahna GV.
    Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
    [Abstract] [Full Text] [Related]

  • 4. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA, Jeanmonod P, Schuld J, Moussavian MR, Schilling MK, Kollmar O.
    Dig Surg; 2012 Mar; 29(6):484-91. PubMed ID: 23392293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.
    Popiela T, Kedra B, Sierzega M, Gurda A.
    Hepatogastroenterology; 2004 Mar; 51(59):1484-8. PubMed ID: 15362783
    [Abstract] [Full Text] [Related]

  • 7. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ, López Cillero P, Rufián Peña S, Solórzano Peck G, Miño Fugarolas G, Pera Madrazo C.
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Role octreotide in prevention of complications after pancreatoduodenal resections].
    Shatverian GA, Ratnikova NP, Mikhaĭlov IuE, Bedzhanian AL, Sidorov AN, Fisenko EP, Skipenko OG.
    Khirurgiia (Mosk); 2004 Oct; (2):56-60. PubMed ID: 14997883
    [No Abstract] [Full Text] [Related]

  • 10. Pancreatic fistula after pancreatic head resection; incidence, significance and management.
    Hashimoto N, Yasuda C, Ohyanagi H.
    Hepatogastroenterology; 2003 Oct; 50(53):1658-60. PubMed ID: 14571810
    [Abstract] [Full Text] [Related]

  • 11. Does prophylactic octreotide benefit patients undergoing elective pancreatic resection?
    Yeo CJ.
    J Gastrointest Surg; 1999 Oct; 3(3):223-4. PubMed ID: 10809581
    [No Abstract] [Full Text] [Related]

  • 12. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD, Paik KY, Park IY, Yoo YK.
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic irrigation around a pancreaticojejunostomy for the treatment of a pancreatic fistula after a pancreaticoduodenectomy in patients with a risky pancreatic remnant.
    Nakano H, Asakura T, Sakurai J, Koizumi S, Asano T, Watanabe T, Otsubo T.
    Hepatogastroenterology; 2008 Feb; 55(82-83):717-21. PubMed ID: 18613441
    [Abstract] [Full Text] [Related]

  • 14. Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.
    Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM.
    Ann Surg; 2018 Apr; 267(4):608-616. PubMed ID: 28594741
    [Abstract] [Full Text] [Related]

  • 15. Toward zero pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy.
    Rosso E, Bachellier P, Oussoultzoglou E, Scurtu R, Meyer N, Nakano H, Verasay G, Jaeck D.
    Am J Surg; 2006 Jun; 191(6):726-32; discussion 733-4. PubMed ID: 16720139
    [Abstract] [Full Text] [Related]

  • 16. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.
    Lai EC, Lau SH, Lau WY.
    Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946
    [Abstract] [Full Text] [Related]

  • 17. Stenting and the rate of pancreatic fistula following pancreaticoduodenectomy.
    Moriya T, Clark CJ, Kirihara Y, Kendrick ML, Reid Lombardo KM, Que FG, Farnell MB.
    Arch Surg; 2012 Jan; 147(1):35-40. PubMed ID: 22250109
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial.
    Kurumboor P, Palaniswami KN, Pramil K, George D, Ponnambathayil S, Varma D, Aikot S.
    J Gastrointest Surg; 2015 Nov; 19(11):2038-44. PubMed ID: 26302879
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of the prophylactic use of octreotide after a pancreaticoduodenectomy.
    Moon HJ, Heo JS, Choi SH, Joh JW, Choi DW, Kim YI.
    Yonsei Med J; 2005 Dec 31; 46(6):788-93. PubMed ID: 16385654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.